Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Porcine Models of Heart Regeneration.
Velayutham N, Yutzey KE. Velayutham N, et al. J Cardiovasc Dev Dis. 2022 Mar 23;9(4):93. doi: 10.3390/jcdd9040093. J Cardiovasc Dev Dis. 2022. PMID: 35448069 Free PMC article. Review.
Btg1 and Btg2 regulate neonatal cardiomyocyte cell cycle arrest.
Velayutham N, Calderon MU, Alfieri CM, Padula SL, van Leeuwen FN, Scheijen B, Yutzey KE. Velayutham N, et al. J Mol Cell Cardiol. 2023 Jun;179:30-41. doi: 10.1016/j.yjmcc.2023.03.016. Epub 2023 Apr 14. J Mol Cell Cardiol. 2023. PMID: 37062247 Free PMC article.
P53 Activation Promotes Maturational Characteristics of Pluripotent Stem Cell-Derived Cardiomyocytes in 3-Dimensional Suspension Culture Via FOXO-FOXM1 Regulation.
Velayutham N, Garbern JC, Elwell HLT, Zhuo Z, Rüland L, Elcure Alvarez F, Frontini S, Rodriguez Carreras Y, Eichholtz M, Ricci-Blair E, Shaw JY, Bouffard AH, Sokol M, Mancheño Juncosa E, Rhoades S, van den Berg D, Kreymerman A, Aoyama J, Höfflin J, Ryan H, Ho Sui S, Lee RT. Velayutham N, et al. J Am Heart Assoc. 2024 Jul 2;13(13):e033155. doi: 10.1161/JAHA.123.033155. Epub 2024 Jun 27. J Am Heart Assoc. 2024. PMID: 38934864 Free PMC article.
Corrigendum: Stylopine: a potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy.
Velayutham NK, Thamaraikani T, Wahab S, Khalid M, Ramachawolran G, Abullais SS, Wong LS, Sekar M, Gan SH, Ebenezer AJ, Ravikumar M, Subramaniyan V, Izzati Mat Rani NN, Wu YS, Jeyabalan S. Velayutham NK, et al. Front Pharmacol. 2024 Jan 17;15:1343756. doi: 10.3389/fphar.2024.1343756. eCollection 2024. Front Pharmacol. 2024. PMID: 38299157 Free PMC article.
12 results